Interim Guidance on the Voluntary Labeling of Milk and Milk Products From Cows That Have Not Been Treated With Recombinant Bovine Somatotropin

Summary

The Food and Drug Administration (FDA) is publishing interim guidance on the labeling of milk and milk products from cows not treated with recombinant bovine somatotropin in response to requests from several States and industry and consumer representatives.